71 related articles for article (PubMed ID: 21413017)
1. Epigenetic markers for chemosensitivity and chemoresistance in pancreatic cancer--a review.
Dhayat S; Mardin WA; Mees ST; Haier J
Int J Cancer; 2011 Sep; 129(5):1031-41. PubMed ID: 21413017
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers and pathways of chemoresistance and chemosensitivity for personalized treatment of pancreatic adenocarcinoma.
Zemanek T; Melichar B; Lovecek M; Soucek P; Mohelnikova-Duchonova B
Pharmacogenomics; 2019 Jan; 20(2):113-127. PubMed ID: 30539680
[TBL] [Abstract][Full Text] [Related]
3. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
4. Advancements in the management of pancreatic cancer: 2013.
Saif MW
JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
[TBL] [Abstract][Full Text] [Related]
5. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.
Frank TS; Sun X; Zhang Y; Yang J; Fisher WE; Gingras MC; Li M
Cancer Lett; 2015 Jul; 363(1):1-6. PubMed ID: 25890222
[TBL] [Abstract][Full Text] [Related]
6. Molecular alterations contributing to pancreatic cancer chemoresistance.
Rajabpour A; Rajaei F; Teimoori-Toolabi L
Pancreatology; 2017; 17(2):310-320. PubMed ID: 28065383
[TBL] [Abstract][Full Text] [Related]
7. Treatment options for advanced pancreatic cancer: a review.
Warsame R; Grothey A
Expert Rev Anticancer Ther; 2012 Oct; 12(10):1327-36. PubMed ID: 23176620
[TBL] [Abstract][Full Text] [Related]
8. Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.
Khan MA; Zubair H; Srivastava SK; Singh S; Singh AP
Adv Exp Med Biol; 2015; 889():71-87. PubMed ID: 26658997
[TBL] [Abstract][Full Text] [Related]
9. Noncoding Rnas Emerging as Novel Biomarkers in Pancreatic Cancer.
Garajová I; Balsano R; Tommasi C; Giovannetti E
Curr Pharm Des; 2018; 24(39):4601-4604. PubMed ID: 30659532
[TBL] [Abstract][Full Text] [Related]
10. Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer.
El Maalouf G; Le Tourneau C; Batty GN; Faivre S; Raymond E
Cancer Treat Rev; 2009 Apr; 35(2):167-74. PubMed ID: 19027240
[TBL] [Abstract][Full Text] [Related]
11. A review of systemic therapy for advanced pancreatic cancer.
El-Rayes BF; Philip PA
Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429
[TBL] [Abstract][Full Text] [Related]
12. New avenues in pancreatic cancer: exploiting microRNAs as predictive biomarkers and new approaches to target aberrant metabolism.
Capula M; Mantini G; Funel N; Giovannetti E
Expert Rev Clin Pharmacol; 2019 Dec; 12(12):1081-1090. PubMed ID: 31721608
[No Abstract] [Full Text] [Related]
13. Pancreatic cancer: the role of molecular markers in diagnosis and management.
Lowery MA; O'Reilly EM
Clin Adv Hematol Oncol; 2011 Dec; 9(12):900-8. PubMed ID: 22252658
[TBL] [Abstract][Full Text] [Related]
14. Chemosensitivity testing and test-directed chemotherapy in human pancreatic cancer.
Kornmann M; Beger HG; Link KH
Recent Results Cancer Res; 2003; 161():180-95. PubMed ID: 12528808
[TBL] [Abstract][Full Text] [Related]
15. Molecular landscape of pancreatic cancer: implications for current clinical trials.
Heestand GM; Kurzrock R
Oncotarget; 2015 Mar; 6(7):4553-61. PubMed ID: 25714017
[TBL] [Abstract][Full Text] [Related]
16. Parsing pancreatic cancer.
Cancer Discov; 2015 May; 5(5):459. PubMed ID: 25788659
[No Abstract] [Full Text] [Related]
17. PKR2 and β-catenin genes regulates pancreatic cancer chemosensitivity.
Zhong RL; Li Y; Fang Z; Fang KF; Wang L
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):48-54. PubMed ID: 28121357
[TBL] [Abstract][Full Text] [Related]
18. TAMing pancreatic cancer: combat with a double edged sword.
Lankadasari MB; Mukhopadhyay P; Mohammed S; Harikumar KB
Mol Cancer; 2019 Mar; 18(1):48. PubMed ID: 30925924
[TBL] [Abstract][Full Text] [Related]
19. Molecular versus conventional markers in pancreatic cancer.
Friess H; Kleeff J; Gumbs A; Büchler MW
Digestion; 1997; 58(6):557-63. PubMed ID: 9438602
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer: translational research aspects and clinical implications.
Ansari D; Chen BC; Dong L; Zhou MT; Andersson R
World J Gastroenterol; 2012 Apr; 18(13):1417-24. PubMed ID: 22509073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
